Just for clarity: the EM sets out how schedule 1 allows for an exemption to be withdrawn should the product not be meeting certain conditions set at the outset. Can you explain the other circumstances where an unanticipated harm emerges in relation to a particular product or category of products, and the capacity for ASIC to deal with that problem?